IPO registrations (S-1, F-1) · Registrants

ILLUMINA, INC.

SEC CIK
1110803 · filings on EDGAR ↗
Name on the registration
ILLUMINA INC
Former names
ILLUMINA INC (2000–2019)
Registration
Form S-1, first filed 2000-04-03, last 2000-07-27; 1 initial registration, 6 amendments
Outcome
Final prospectus filed 2000-07-28
Industry (SIC)
Laboratory Analytical Instruments 3826
Incorporated in
DE
Business address
5200 ILLUMINA WAY, San Diego, CA 92122
EIN
33-0804655
Ticker
ILMN (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
ILLUMINA, INC. on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2000-07-27)
Final price
$16.00 per share, above the range (424B4 filed 2000-07-28, an initial public offering)
Shares sold
6,000,000
Gross proceeds
$96,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ILMN
Lead underwriters
Goldman Sachs (2,551,200 shares); Cowen (1,274,400 shares); J.P. Morgan (1,274,400 shares)
Syndicate
Hambrecht & Quist; BofA Securities (120,000); Bear Stearns (120,000); A.G. Edwards (120,000); Edward D. Jones & Co., L.P (120,000); Lehman Brothers (120,000); Baird (60,000); William Blair (60,000); Legg Mason (60,000); Ramirez & Co. (60,000); Sutro & Co. Incorporated (60,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2000-04-03S-1S-1 (registration)ILLUMINA INC0001012870-00-001863 ↗
2000-07-03S-1/AS-1/A (amendment)ILLUMINA INC0001012870-00-003639 ↗
2000-07-10S-1/AS-1/A (amendment)ILLUMINA INC0001021408-00-002143 ↗
2000-07-19S-1/AS-1/A (amendment)ILLUMINA INC0001072993-00-000523 ↗
2000-07-26S-1/AS-1/A (amendment)ILLUMINA INC0001012870-00-003960 ↗
2000-07-27S-1/AS-1/A (amendment)ILLUMINA INC0001012870-00-003981 ↗
2000-07-27S-1/AS-1/A (amendment)ILLUMINA INC0001072993-00-000539 ↗
2000-07-28424B4424B4 (final prospectus)ILLUMINA INC0001012870-00-004000 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-07-27S-1/Aregistration statement$13.00–$15.006,000,000-Nasdaq ILMN4primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3document ↗
2000-07-28424B4final prospectus$16.006,000,000$96,000,000Nasdaq ILMN14primary document; price sentence, shares headline, proceeds table, underwriting table 13, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
STUELPNAGEL JOHN RDirector,OfficerSr VP and COO; Sr VP of Operations & COO292006–2008
WALT DAVID RDirector3382006–2016
FLATLEY JAY TDirector; Director,Officer; OfficerCEO; CEO and Chairman of the Board; Chief Executive Officer; President and CEO; President & CEO; President & CEO Officer3432006–2021
CABRAL PAULETTE DOfficerVice President Human Resources12006
HENRY CHRISTIAN OOfficerCFO, VP Finance; EVP & Chief Commercial Officer; Senior VP and CFO; Sr VP and GM; Sr VP and GM Genomic Solutions; Sr VP & CFO; Sr VP & Chief Commercial Ofcr; Sr VP & Chief Commercial Offic; Sr VP, General Manager Genomic; Sr VP & GM Genomic Solutions; Sr VP, GM Genomic Solutions; Sr VP, GM Life Science; Sr VP, GM Life Sciences & CFO; SVP and CFO; SVP, Chief Commercial Officer; SVP/GM Genomic Solutions1212006–2017
ORPIN TRISTANOfficerEVP Clinical Genomics; Sr VP & Chief Commercial Off.; Sr VP & Chief Commercial Offcr; Sr VP & Chief Commercial Offic; Sr VP, Commercial Operations; Sr VP of Commercial Operations; SVP & Chief Commercial Officer; VP Worldwide Sales; VP Worldwide Sales Officer1212006–2016
Holden ArthurOfficerSr. VP Corp and Market Dev; Sr VP Corp & Market Dev32006–2007
Cabou ChristianOfficerSenior VP, General Counsel; Sr VP and General Counsel; Sr. VP and General Counsel; Sr VP Gen Counsel & Secretary; Sr VP & General Counsel; Sr. VP, General Counsel522006–2013
BRADBURY DANIELDirector892006–2017
EASTHAM KARINDirector382006–2019
GRINT PAUL CDirector142006–2013
RASTETTER WILLIAM HDirector352006–2016
GOLDSTEIN JACKDirector92006–2010
BOWMAN A BLAINEDirector472007–2018
West JohnOfficerChief Executive Officer; Sr VP & GM DNA Sequencing; Sr VP & GM, DNA Sequencing; Sr. VP & GM DNA Sequencing212007
WHITFIELD ROY ADirector412007–2016
Heath GregoryOfficerSr. VP and GM, Diagnostics; Sr VP & General Manager332008–2013
McComb JoelOfficerSr. VP and GM, Life Sciences; Sr VP & General Manager52008–2010
Ronaghi MostafaOfficerSr Vice President & CTO; Sr VP Chief Technology Officer; Sr VP & CTO; SVP & CTO; SVP, Entrepreneurial Devlopmt782008–2020
MOELLER GERALDDirector232010–2015
Naclerio NicholasOfficerSr VP, Corp Develop & GM; Sr VP, Corp Development; Sr VP, Corporate Development; Sr VP, Corporate & Venture Dev; Sr VP & General Manager; SVP Corporate Development; SVP Corp & Venture Development492011–2016
Stapley MarcOfficerCFO; EVP & Chief Administrative Ofc; EVP Strategy & Corp Developmt; Sr VP & CFO672012–2019
Posard Matthew L.OfficerSr VP & General Manager; Sr VP & GM, Consumer Genomics82012–2013
Bianchi Paul LOfficerSr VP Human Resources; Sr VP, Human Resources; Sr. VP, Human Resources242012–2016
Lewis Mark LOfficerSr VP & General Manager; Sr VP & GM Molecular Biology; SVP & GM Molecular Biology102012–2013
EPSTEIN ROBERT SDirector472012–2025person page Fuzzy
Bouchard MichelOfficer; OtherChief Accounting Officer; VP, Finance; VP, Finance & Chief Accounting602013–2017
Dadswell CharlesOfficerSr VP & General Counsel; SVP & General Counsel; SVP, General Counsel1142013–2024
Klausner RichardOfficerSr VP, Chief Medical Officer112013–2016
deSouza Francis ADirector,Officer; OfficerPresident; President and CEO672013–2023
Huber JeffDirector112014–2017
OSTADAN OMEADOfficerEVP Ops, Products, Strategy; Sr VP Product Dev & Operations; SVP Mktg, Prod & Strat Plan502015–2020
ARNOLD FRANCESDirector202016–2025
SCHILLER PHILIP WDirector142016–2026
SAMAD SAMOfficerSr. VP and CFO; SVP and CFO252017–2022
DORSA CAROLINEDirector162017–2026
Hampton Malcolm GarretOfficerEVP Clinical Genomics Group; SVP Clinical Genomics Group82017–2020
THOMPSON JOHN WENDELLDirector72017–2022
Van Oene MarkOfficerSVP Chief Commercial Officer292017–2020
MCGINNIS KAREN KOfficerVP, Chief Accounting Officer162017–2021
GUTHART GARY SDirector122017–2025
Hoyt Aimee LOfficerSVP, Chief People Officer302018–2023
RAGUSA ROBERT POfficerSVP, Global Quality & Ops142019–2021
SIEGEL SUSAN EDirector102019–2026
GOSWAMI JOYDEEPOfficerSVP Chief Financial Officer; SVP, Chief Financial Officer; SVP Corp Business Development172019–2024
Febbo Phillip G.OfficerSVP Chief Medical Officer182019–2023
TOUSI SUSAN HOfficerSVP, Chief Commercial Officer; SVP Product Development522019–2023
Gottlieb ScottDirector152020–2026
Aravanis AlexanderOfficerSVP, Chief Technology Officer172020–2023
Reeves Kathryne GambrellOfficerSVP, Chief Marketing Officer122020–2024
TORRES JOSEOfficerVP, Chief Accounting Officer42021–2022
Pegels Kevin CarlOfficerChief of Global Operations182021–2026
Rollins CarissaOfficerSVP, Chief Information Officer112022–2025
Frank John EdwardOfficerChief Public Affairs Officer42022–2023
Ericksen Scott DOfficerVP, Chief Accounting Officer142022–2026
Teno AndrewDirector22023
MACMILLAN STEPHEN PDirector32023–2024
Ullem Scott B.Director162023–2026
Barnard StevenOfficerSVP, Chief Technology Officer152023–2026
Thaysen JacobDirector,OfficerChief Executive Officer122023–2026
Leckman PatriciaOfficerSVP, Chief People Officer122024–2026
Dhingra AnkurOfficerSVP, Chief Financial Officer52024–2026
Wedel Christensen JakobOfficerSVP, Strategy/Corp Development112024–2026
RICHO ANNADirector42024–2026
Cunningham EverettOfficerSVP, Chief Commercial Officer42024–2025
Davies Scott MOfficerChief Legal Officer; Interim General Counsel152024–2026
Meister Keith A.Director142025–2026
KING DAVID PDirector22026
Skovronsky DanielDirector22026
Sullivan Michael COfficerChief Commercial Officer22026
Coletti Julie AnnOfficerChief Legal Officer22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationIllumina Inc.CAState business registriesname and state
Business registrationIllumina, Inc.CAState business registriesname and state
Business registrationILLUMINA, INCCAState business registriesname and state
Business registrationILLUMINA, INC.CAState business registriesEIN (EXACT, as the state registration reports it)
Business registrationILLUMINA, INC.CAState business registriesname and state
ContractorILLUMINA INCCANonprofit contractors (Form 990)name and state
Federal award recipientILLUMINA, INC.CAFederal spending (USAspending)name and state
Lobbying registrantILLUMINA, INC.CAFederal lobbying (LDA)name and state
Paying companyIllumina, Inc.CAOpen Payments (drug and device company payments)name and state
Patent assigneeIllumina, Inc.CAPatents (USPTO)name and state
SEC filerILLUMINA, INC.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerIllumina, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorILLUMINA, INC.EIN (EXACT)
Lobbying clientILLUMINAFederal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Lobbying clientILLUMINA, INC.Federal lobbying (LDA)name and state
Person pageRobert S EpsteinPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Laboratory Analytical Instruments, CA first:

More with this interest.

In other datasets, the same topic (Technology) in CA:

Interests: Laboratory Analytical Instruments · Technology